^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
BI 836880
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Boehringer Ingelheim
Drug class:
VEGF inhibitor, Angiopoietin 2 inhibitor
Related drugs:
